Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: Nashville TN, Cincinnati OH, Columbus OH, Charlotte NC,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase1, Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Denver CO, Nashville TN, Germantown TN, Little Rock AR,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase1, Phase2, Recruiting

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

for
Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
Location: Nashville TN, Chapel Hill NC, Denver CO
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT06940739

Phase1, Phase2, Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Nashville TN, Chicago IL, Durham NC, Detroit MI,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase1, Phase2, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Nashville TN, Cincinnati OH, Detroit MI, Fairway KS,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Nashville TN, St Louis MO, Chapel Hill NC, Ann Arbor MI,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase2, Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Nashville TN, Iowa City IA, Dallas TX, Fullerton CA,
Sponsor: TORL Biotherapeutics, LLC

Sex: All

Age: 18+

Code: NCT07439653

Phase1, Phase2, Recruiting

Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC)
Location: Nashville TN, Grand Rapids MI
Sponsor: Immunomic Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT07652242

Phase1, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Nashville TN, Atlanta GA, Columbus OH, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase1, Recruiting

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for
Advanced NRAS-Mutant Melanoma,
Location: Nashville TN, Grand Rapids MI, Fairfax VA, New York NY,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07584226

Phase1, Recruiting

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Nashville TN, Pittsburgh PA, Irving TX, Houston TX,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07493512

Phase1, Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for
Lymphoma
Location: Nashville TN, St Louis MO, Columbus OH, Chicago IL,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase2, Recruiting

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Nashville TN, Knoxville TN, St Louis MO, Munster IN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07154290

Phase2, Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

for
Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma,
Location: Nashville TN
Sponsor: AvenCell Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284433

Phase1, Phase2, Recruiting

Study in Advanced Solid Tumor Patients

for
Advanced Solid Tumor
Location: Nashville TN, Houston TX, San Antonio TX,
Sponsor: Callio Therapeutics

Sex: All

Age: 18+

Code: NCT07300943

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

for
Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer,
Location: Nashville TN, Orlando FL, Houston TX
Sponsor: Phrontline Biopharma

Sex: All

Age: 18+

Code: NCT07181473

Phase1, Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for
Breast Neoplasms, Neoplasm Metastasis
Location: Nashville TN, Tupelo MS, Newnan GA, Edgewood KY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase3, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: Denver CO, Nashville TN, Cleveland OH, Jacksonville FL,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase1, Recruiting

A Study of CTD402 in T-ALL/LBL Patients

for
Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
Location: Nashville TN, Chicago IL, Rochester MN, Houston TX,
Sponsor: Imviva Bio

Sex: All

Age: 1+

Code: NCT07070219

Phase1, Phase2, Recruiting

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

for
Advanced Solid Tumor
Location: Nashville TN, Scottsdale AZ
Sponsor: Strand Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07751042

Phase1, Phase2, Recruiting